Atara Biotherapeutics, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:ATRA) | MetaTrader

Open full chart

News

Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End

Uniqure Catapults 60% On A Gene Therapy Shock From The FDA

ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know

Morning News Wrap-Up, 5/7/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Atara schedules FDA meeting on tabelecleucel license application

Pierre Fabre requests FDA meeting on tabelecleucel approval

Atara extends $9M milestone payment deadline to 2028

Atara Bio director Huang James sells $489k in shares

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

FDA rejects Atara’s tabelecleucel application in surprise reversal

Atara Biotherapeutics stock plunges after FDA rejects cancer therapy

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)